MARK C. BROWN P.A. NPI 1578747515

NPI Details

Mark C. Brown, P.A. is a medical physician assistant in Fairhope, AL with 19 years of experience. Mark C. Brown, P.A. NPI is 1578747515. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

7550 ASSUNTA CT
FAIRHOPE, AL
ZIP 36532-069
Phone: (251) 928-4944
Fax: (251) 928-2086

The NPI 1578747515 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Administration of chemotherapy into growth, 1-7 (HCPCS:96405)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Biopsy of ear (HCPCS:69100)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:17272)
• Removal of skin tag, 1-15 skin tags (HCPCS:11200)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:17271)
• Destruction of skin growth, 15 or more growths (HCPCS:17111)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:17281)
• Punch biopsy, first skin growth (HCPCS:11104)
• Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm (HCPCS:12042)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:11622)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:11642)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 12/27/2007 and was last updated on 1/25/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: